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Over the past few years, the increasing role of risk factors and determinants of tuberculosis (TB) has been
sufficiently elucidated [1, 2]. A number of noncommunicable conditions that are associated with TB have
been identified [3]. These are particularly important at the start of the new millennium, as more and more
low- and middle-income countries have entered a phase of epidemiological transition characterised by
growing epidemics of noncommunicable diseases and conditions replacing infectious diseases as the main
causes of ill health and deaths [4, 5].
The harmful use of alcohol is one of the four key risk factors for major noncommunicable diseases [6, 7]
that has also emerged as a risk factor for some infectious diseases, including TB [7, 8]. The WHO Global
strategy to reduce the harmful use of alcohol, endorsed by the World Health Assembly in 2010, defines
broadly the “harmful use of alcohol” as “drinking that causes detrimental health and social consequences
for the drinker, the people around the drinker and society at large, as well as the patterns of drinking that
are associated with increased risk of adverse health outcomes” [9].
The links between heavy drinking and TB had been described in the medical literature since the middle of
the past century [10], but only recently, due to results of well-designed studies summarised in subsequent
systematic reviews and meta-analyses [11, 12], the causal relationship of TB with heavy alcohol
consumption and alcohol use disorders had been firmly established and taken into consideration in the
estimates of alcohol-attributable disease burden [13–15].
In this context, the article of IMTIAZ et al. [16] in the European Respiratory Journal is an important step
forward in quantifying the contribution of alcohol consumption to the burden of TB at global and
national levels, as well as the contribution of the TB-related morbidity and mortality to the overall
alcohol-attributable disease burden. These new estimates suggest that in 2014 about 170000 deaths due to
TB were attributable to alcohol consumption worldwide, and as many as 17% of incident cases of TB and
15% of deaths due to TB could be prevented by eliminating the harmful use of alcohol. Hence,
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identification and implementation of effective strategies and interventions to reduce the harmful use of
alcohol is of global relevance and significant importance for TB prevention and care. There are several
practical implications that follow these findings.
First, to promote public health action one must acknowledge the overall relevance of reducing harmful use
of alcohol for TB control. Development, implementation and enforcement of alcohol control policies have
a potential to alleviate the role of the harmful use of alcohol among the key risk factors for TB and
associated mortality in the population. This is particularly important for high-burden countries suffering
from the dual burden of TB epidemics and the harmful use of alcohol.
Second, the implication for action is linked to targeted prevention and treatment interventions focused on
high risk groups and individuals, and delivered within health and social care systems. In recent years the
role of heavy drinking and alcohol use disorders in the incidence and progression of TB, as well as their
impact on TB treatment adherence has been documented in an increasing number of countries in different
continents, including India [17], Kazakhstan [18], Poland [19], Vietnam [20], South Africa [21, 22] and
Uganda [23]. The role of heavy drinking and alcohol use disorders in favouring development and spread
of drug-resistant TB has been confirmed in studies conducted in diverse economic and cultural contexts
[24–27]. In spite of increasingly documented and quantified contribution of the harmful use of alcohol to
development and progression of TB and poor treatment outcomes, the priority in public health given to
addressing this risk factor is still far from what could be expected based on the evidence available. Thus
far, very few pilot projects have assessed the feasibility and effectiveness of interventions focused on
alcohol use disorders in management of TB [28]; results of integrating alcohol treatment interventions into
routine TB care for patients with alcohol dependence in one Russian city are not particularly encouraging
[29]. There is an urgent need to invest in identifying the most appropriate and efficient treatment options
and delivery models for people affected by TB and alcohol use disorders.
There are many challenges which need still to be addressed. For population-based epidemiological studies
it is important to further explore the thresholds of alcohol exposure that have an impact on incidence and
progression of TB. The article by IMTIAZ et al. [16] indicates alcohol exposure thresholds used in the
analysis which are based on currently available evidence and are different for men and women. However,
this issue definitely requires further research as the operationalisation of alcohol exposure and the use of
compatible, comparable and clinically relevant measures across the studies continues to be a challenge; this
hampers translation of research findings into clinical practice and their use in prevention strategies and
interventions. For clinicians it is important to identify precisely defined health conditions such as alcohol
dependence or alcohol use disorder of specified severity, and preferably discrete patterns of alcohol use,
including the hazardous use of alcohol, so that the most effective interventions and treatment options for
patients with TB can be designed. Currently a range of treatment options with proven effectiveness is
available for management of hazardous drinking and alcohol use disorders from screening and brief
interventions for risky patterns of alcohol consumption to pharmacological and structured psychosocial
interventions for management of alcohol dependence [30–32].
In spite of current gaps in our knowledge, there are two major public health approaches that are justified
in view of all accumulated evidence and new data presented by IMTIAZ et al. [16]. The first approach is
related to systematic screening for alcohol use and early identification of alcohol use disorders in all
patients engaged with prevention and treatment services for TB. Health professionals in these settings
should be trained to identify not only alcohol use disorders, but also patterns of alcohol use associated
with increased risk of negative health consequences including TB-related risks. In other words, hazardous
patterns of alcohol consumption and alcohol use disorders must be recognised and appropriate
interventions and treatment options implemented. These may include simple advice and brief
interventions or expand to pharmacotherapy of alcohol dependence, if this is diagnosed, and referral to
specialists for support in organising and implementing structured treatment.
The second approach is related to active screening and identification of TB cases among people with
alcohol use disorders, including those enrolled in special treatment programmes for alcohol dependence.
Special attention would need to be paid to high risk groups for these conditions including the homeless,
people released from prisons, and those using other psychoactive substances such as tobacco and illicit
drugs. Individuals with alcohol and comorbid drug use disorders present a particularly high risk for TB
[27], and, in addition, injection drug use is a well-established risk factor for HIV and hepatitis C [33, 34].
Management of TB and alcohol use disorder comorbidity requires intensive patient support and social
protection measures. Though this means additional resources, the cost-effectiveness of these interventions
is likely to be high in view of potential to increase adherence to treatment regimens, prevent
multidrug-resistant TB and mitigate socioeconomic effects and risk of further impoverishment associated
with high societal costs. Health education, counselling, psychosocial and material support to patients are
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emphasised as important elements of TB case management in the new WHO TB treatment guidelines
released in 2017 [35].
Finally, at population level, success can be achieved only if the variety of available public health
approaches is effectively supported by coherent and linked policies and strategies aimed simultaneously at
ending TB as a public health problem and reducing the harmful use of alcohol. To ensure this happens,
the mounting evidence of the impact of the harmful use of alcohol on incidence and treatment outcomes
of TB requires appropriate recognition at the level of strategic planning and political commitment backed
by resources. The need for an integrated approach to care and prevention of complex public health
problems like TB and harmful use of alcohol, built on strong health services and on societies as a whole is
obvious. This approach is embedded in the 2030 Agenda for Sustainable Development where both ending
TB and prevention and treatment of substance abuse are highlighted [36]. The strong causal relationship
existing for noncommunicable conditions and TB, demanding synergistic, combined interventions, is also
one of the key issues for discussion at the First WHO Global Ministerial Conference “Ending tuberculosis
in the sustainable development era – a multisectoral response” to be held in Moscow on November 16–17,
2017. The expected Ministerial Declaration needs to emphasise the need for synergies and identify bold
deliverables that can be subsequently put on the table of heads of state at the High Level Meeting on TB of
the UN General Assembly in 2018. This will ensure commitment and willingness to finally respond
adequately and reduce dramatically the burden of TB and the harmful use of alcohol that are ravaging
humankind.
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